Galderma Receives FDA Approval to Market Restylane Lyft

  Galderma, a global healthcare company that manufactures Restylane® and Dysport®, announced on July 2nd that they have received FDA approval to market Restylane® Lift for volume loss in the cheek area in patients over 21. Restylane® Lyft was formerly marketed as Perlane-L®, an injectable used to smooth wrinkles in the face and restore volume. …

Galderma Receives FDA Approval to Market Restylane Lyft Read More »